ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,289Medicare Part D Prescriptions Filled, Including Refills

Rank: 80 out of 625

$819K Total Retail Price of All Prescriptions

Rank: 58 out of 625

815 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 815 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 815 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 9,263 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
HYDROCODONE-ACETAMINOPHEN 575 342 S3 1 4
LEVOTHYROXINE SODIUM 412 337 2 3
ZOLPIDEM TARTRATE 365 252 3 13
OMEPRAZOLE 337 260 4 6
LISINOPRIL 334 247 5 5
PRAVASTATIN SODIUM 332 244 6 8
SIMVASTATIN 309 239 7 2
AMLODIPINE BESYLATE 288 264 8 1
TRAMADOL HCL 232 157 9 16
GABAPENTIN 229 156 10 14
ATORVASTATIN CALCIUM 227 199 11 9
WARFARIN SODIUM 191 169 12 20
METOPROLOL TARTRATE 180 156 13 11
HYDROCHLOROTHIAZIDE 175 165 14 12
FUROSEMIDE 162 119 15 7
METOPROLOL SUCCINATE 146 129 16 15
NEXIUM 140 109 17 21
LOSARTAN POTASSIUM 135 134 18 18
FENTANYL 118 68 S2 19 110
CITALOPRAM HBR 116 78 20 24
CLOPIDOGREL 112 92 21 30
METFORMIN HCL 112 102 21 10
SYNTHROID 111 99 23 39
PREDNISONE 104 86 24 37
MELOXICAM 102 91 25 31
CRESTOR 101 85 26 17
NAMENDA 98 97 27 45
METFORMIN HCL ER 93 79 28 41
CARVEDILOL 92 68 29 23
POTASSIUM CHLORIDE 92 68 29 19
RANITIDINE HCL 91 47 31 25
PLAVIX 89 77 32 43
PANTOPRAZOLE SODIUM 86 71 33 44
ATENOLOL 86 69 33 22
SERTRALINE HCL 80 64 35 26
ADVAIR DISKUS 77 61 36 63
GEMFIBROZIL 75 34 37 127
SULFAMETHOXAZOLE-TRIMETHOPRIM 75 46 37 116
MIRTAZAPINE 70 65 39 69
CARISOPRODOL 69 0 R 40 89
DIGOXIN 69 68 40 55
BENAZEPRIL HCL 66 56 42 35
CYMBALTA 66 49 42 46
CYCLOBENZAPRINE HCL 64 28 R 44 65
DONEPEZIL HCL 62 59 45 33
PROMETHAZINE HCL 61 19 R 46 84
ALENDRONATE SODIUM 61 50 46 34
TRAZODONE HCL 61 42 46 51
LEVOFLOXACIN 59 43 49 90
ISOSORBIDE MONONITRATE ER 59 52 49 49
PREMARIN 58 37 R 51 105
GLIPIZIDE XL 56 39 52 83
LOSARTAN-HYDROCHLOROTHIAZIDE 55 48 53 38
LIPITOR 54 45 54 75
FLUOXETINE HCL 53 28 55 62
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 44 56 27
TAMSULOSIN HCL 51 50 56 36
BYSTOLIC 50 41 58 97
ESCITALOPRAM OXALATE 50 47 58 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.